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Abstract
Background: BmK I, a site-3-specific modulator of voltage-gated sodium channels (VGSCs), causes pain and
hyperalgesia in rats, while BmK IT2, a site-4-specific modulator of VGSCs, suppresses pain-related responses. A
stronger pain-related effect has been previously attributed to Buthus martensi Karsch (BmK) venom, which points
out the joint pharmacological effect in the crude venom.
Methods: In order to detect the joint effect of BmK I and BmK IT2 on ND7-23 cells, the membrane current was
measured by whole cell recording. BmK I and BmK IT2 were applied successively and jointly, and the synergistic
modulations of VGSCs on ND7-23 cells were detected.
Results: Larger peak INa and more negative half-activation voltage were elicited by joint application of BmK I and
BmK IT2 than by application of BmK I or BmK IT2 alone. Compared to the control, co-applied BmK I and BmK IT2
also significantly prolonged the time constant of inactivation.
Conclusions: Our results indicated that site-4 toxin (BmK IT2) could enhance the pharmacological effect induced
by site-3 toxin (BmK I), suggesting a stronger effect elicited by both toxins that alone usually exhibit opposite
pharmacological effects, which is related to the allosteric interaction between receptor site 3 and site 4. Meanwhile,
these results may bring a novel perspective for exploring the underlying mechanisms of scorpion sting-induced pain.
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Background
Voltage-gated sodium channels (VGSCs) in most excit-
able cells are involved in generation of action potentials
and closely related to a variety of disorders, including
epilepsy and myotonia [1]. Drugs and toxins are proved
to interact with multiple regions of VGSCs by affecting
their gating properties. So far, at least six different recep-
tor sites are confirmed as pharmacological targets [2].
Scorpion toxins modulating VGSCs are divided into α
and β classes according to their distinct binding sites [3, 4].
The Asian scorpion Buthus martensi Karsch (BmK) is
widely distributed from northwestern China to Mongolia
and Korea and its sting can deliver fierce pain [5]. The
venom of BmK contains many long-chain neuropeptides.
BmK I (a main lethal component), classified as an α-toxin,
can overexcite neurons via inhibiting the inactivation of
VGSCs upon binding to receptor site 3. Moreover, BmK I
may induce spontaneous pain and hyperalgesia after intra-
plantar injections in rats [6–8]. Another component, BmK
IT2, classified as a depressant β-toxin, acts on receptor
site 4 to inhibit peak current and shift the voltage-
dependent activation to more negative membrane poten-
tials, and then leads to inhibition of neuronal excitability
and suppressive effects on nociceptive behavior induced
by formalin [9–11].
Notably, these two components that exhibit opposite
pharmacological effects coexist in the same venom sys-
tem during a long evolutionary history. A stronger pain-
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related behavior has been previously recognized in BmK
venom (containing BmK I and BmK IT2) and not in
BmK I alone [6]. It remains unclear why BmK IT2 did
not suppress, but enhanced pain-related behavior in-
duced by BmK I. In our present study, BmK I and BmK
IT2 are co-applied to DRG-type cell line ND7-23 to
study their synergistic pharmacological effects by whole
cell recording. Our present study aims to provide evi-
dence for synergistic effects of the scorpion toxins
through allosteric interaction among different receptor
sites. It could give us hints to understand the mechan-
ism underlying the joint pharmacological effect and ex-
plain how scorpion stings cause pain.
Methods
Solutions and drugs
In the patch-clamp recordings, pipette solution contained
(mM): 120 CsF, 10 HEPES, 10 EGTA, 15 NaCl (pH 7.25
with CsOH). Bath solution contained (mM): 140 NaCl, 5
HEPES, 1.3 MgCl2, 1 CaCl2, 11 glucose, 4.7 KCl (pH 7.4
with NaOH). The pipette and bath solutions were ad-
justed to osmolarities of 285–290 and 295–300 mOsm,
respectively.
BmK I and Bmk IT2 were purified from BmK venom
by RP-HPLC according to a method previously de-
scribed [12, 13]. The purity of isolated toxins was
checked by mass spectrometry analysis as well as peptide
sequencing, and only those with purity above 99 % were
used. In order to prevent adherence of the toxin to the
vials and the perfusion apparatus, the toxin was dis-
solved in the bath solution and supplemented with
1 mg/mL bovine serum albumin (BSA). BSA (1 mg/mL)
alone does not alter channel function of ND7-23 cells.
Unless otherwise stated, all reagents and drugs were pur-
chased from Sigma-Aldrich.
Cell culture and whole-cell patch clamp recordings
ND7-23 cells were obtained from the Shanghai cell bank
of the Chinese Academy of Science (Shanghai, China).
The cells were cultured in Dulbecco’s modified Eagle
medium (DMEM; Gibco, Invitrogen, USA) and then
supplemented with 2 mM l-glutamine, 10 % heat-
inactivated fetal bovine serum (FBS; Gibco, Invitrogen).
Culture dishes were incubated at 37 °C in a humidified
atmosphere containing 5 % CO2 and subcultured ap-
proximately every 2 to 3 days.
Whole-cell voltage-clamp experiments were performed at
room temperature (21-25 °C). Patch pipettes were fabri-
cated from glass capillary tubes by PC-10 Puller (Narishige,
Japan) with the resistance of 2–3 MΩ.
Currents were amplified with an Axon 200B patch-
clamp amplifer (Axon Instruments, USA) and current
signal entered into the computer through AD/DA con-
verter and sampled by Axon pClamp 8.2 software with
20 KHz sampling frequency. Current signal low-pass fil-
tered at 2 kHz of –3 dB through patch clamp amplifier.
Series resistance (Rs) was compensated (85 ~ 90 %) to
minimize voltage errors, and leak subtraction was per-
formed by a P/4 protocol.
Steady-state activation: the holding potentials were
−120 mV. A 50-ms step of depolarization was applied to
elicited sodium current (INa). The maximal inward
current from 1 to 10 ms was defined as the amplitude of
transient sodium current (INaT). INa was normalized to
the peak INaT. The sodium conductance (G) was calcu-
lated using the formula:
G Vð Þ ¼ I Vð Þ
V – Erev
Where V is voltage values, and G(V) and I(V) are stand
for the conductance G and the current I at the command
voltage V, Erev is the reversal potential of sodium flow esti-
mated from the I–V curve. The conductances were nor-
malized to the maximal value between −90 and +40 mV
and fitted to a Boltzmann equation:
f Vð Þ ¼ –1
1 þ exp V – V1=2‐a
 
=Ka
  þ 1
Where V1/2-a is the voltage at which half-maximal acti-
vation occurs, and Ka describes the slope of the fit.
Steady-state inactivation: the voltage dependence of
steady-state inactivation was analyzed by two-pulse proto-
cols, composed of a 400 ms prepulse, potentials ranging
from −140 to 0 mV with the increments of 10 mV followed
by a test pulse of 0 mV for 80 ms respectively. The ampli-
tudes of the INa were normalized to their maximal value
and plotted as channel availability compared with prepulse
potential. Data were then fitted to a Boltzmann equation:
f Vð Þ ¼ 1 – Cð Þ
1 þ exp V – V1=2‐i
 
=Ki
  þ C
Where V1/2-i is the voltage at which 50 % of the inacti-
vation component is inactivated, Ki is the slope factor,
and C is the steady-state asymptote.
Inactivation kinetics: the inactivation kinetics was ana-
lyzed by fitting the decay course of INaT to a single expo-
nential function:
I ¼ A  exp –t =τð Þ þ ISS
Where τ is the recovery time constant.
Data analysis
The raw data were analyzed by Clampfit 8.2 and Origin
8.5. The results were shown as means ± SEM with the
number of experiments shown in the figure legends. Dif-
ferences between means were analyzed by Student’s test
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or by one-way ANOVA, p < 0.05 was considered a sig-
nificant difference.
Results
Enhanced peak current of sodium channels in ND7-23
after co-application of BmK I and BmK IT2
The current was elicited by a 10 mV step from a holding
potential of −120 mV during depolarization ranging
from −90 to +70 mV. BmK I-mix group (BmK IT2-mix
group) was defined as the ND7-23 cells that had been
treated with the mixture of 400nM BmK I and 400nM
BmK IT2 after pretreatement with 400nM BmK I (BmK
IT2). The currents of sodium channels in ND7-23 were
influenced after application of BMK I or BmK IT2
(Fig. 1a and b). BmK I-mix group and BmK IT2-mix
group showed enhanced peak currents and slow
inactivation, while BmK I-mix group showed entirely
different currents compared to BmK IT2-mix group.
Current–voltage (I-V) curves in the absence or
presence of BmK I or BmK I-mix are shown in
Fig. 1c. In order to minimize diversity of different
ND7-23 cells, all peak currents were normalized to
the maximum peak current in control group. The
normalized peak current was enhanced by over 20 %
of control group in BmK I-mix group and by 10 % in
BmK I group. The enhancement ratio of BmK I-mix
group (INaP = −0.8158 ± 0.2764 at –50 mV; −1.268 ±
0.04475 at –40 mV, n = 5) was significantly larger
than that of BmK I group (INaP = −0.07498 ± 0.007090
at –50 mV; −0.5382 ± 0.2540 at –40 mV, n = 5, p < 0.05)
at –50 mV and –40 mV. Especially, the I-V curve of
BmK I-mix group peaked at −40 mV. The minimum
Fig. 1 Effect of BmK I and BmK IT2 on DRG-type sodium channels. a Representative sodium currents under control conditions (top), after application
of 400 nM BmK I (middle) and after application of 400 nM BmK I and 400 nM BmK IT2 to BmK I group (bottom), shown at intervals of
10 mV. b Representative sodium currents under control conditions (top), after application of 400 nM BmK IT2 (middle), and after application of 400 nM
BmK I and 400 nM BmK IT2 to BmK IT2 group (bottom), shown at intervals of 10 mV. Representative sodium currents under control conditions, and
after application of BSA (panel). c The I-V relationship of the VGSCs on ND7-23 cells in the absence (n = 6), presence of 400 nM BmK I (n = 5) and in
presence of 400 nM BmK I and 400 BmK IT2 (n = 5). d The I-V relationship of the VGSCs on ND7-23 cells in the absence (n = 6), presence of 400nM
BmK IT2 (n = 5) and in presence of 400 nM BmK I and 400 BmK IT2 (n = 5). *p < 0.05
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value was −1.268 ± 0.04475 (Fig. 1c, n = 5, p < 0.05). The I-
V curve of controls and of BmK I peaked at −20 mV. The
minimum value was −0.9405 ± 0.02835 (n = 6) and −1.032
± 0.1610 (n = 5), respectively (Fig. 1c).
The ND7-23 cells were also treated with BmK IT2 and
BmK I mixed with BmK IT2. The current–voltage (I-V)
curves were also draw to count peak current, as shown
in Fig. 1d. According to the report by Tan et al. [9], the
normalized peak INa decreased to 0.8 fold of control
(INaP = −0.8355 ± 0.07998, n = 6) in BmK IT2 group
(Fig. 1d, INaP = −0.6714 ± 0.05813, n = 5, p < 0.05). Com-
pared with the control group, the enhanced peak INa in
BmK IT2-mix group (INaP = −1.026 ± 0.09113, n = 5) was
not significantly different (Fig. 1d, p > 0.05).
Voltage-dependent steady-state activation and inactivation
were modulated by BmK I and BmK IT2
The peak of I-V curves in BmK I-mix group was more
negative at hyperpolarized potentials, which was similar
to the report described by Feng et al. [14]. In order to
compute the relative value of conductance, we calculated
the reversal potential. It was fitted to Boltzmann equa-
tion with its command voltage to draw the conductance-
voltage (G-V) curve (Fig. 2a and b). The midpoint volt-
age (V1/2-a) and slope (Ka) for activation were obtained
from the G-V curve (Table 1). V1/2-a of DRG-type so-
dium channels was significantly affected by post-
treated BmK I and BmK IT2. As follows, the V1/2-a
was shifted to −48.55 ± 1.406 mV (n = 5) in BmK I-mix
group from −29.99 ± 1.225 mV (n = 6) in control group
(Fig. 2a, Table 1, p < 0.01), while BmK I shifted V1/2-a
to −42.02 ± 1.314 mV (Fig. 2a, Table 1, n = 5, p < 0.05).
The Ka was did not show visible changes between
control (Ka = 6.905 ± 0.5381, n = 6) and BmK I group
(Table 1, Ka = 7.047 ± 0.5250, n = 5, p > 0.05), while Ka
was obviously reduced in BmK I-mix group (Table 1,
Ka = 3.288 ± 0.4903, n = 5, p < 0.05). The V1/2-a of DRG-
type sodium channels was shifted to −38.12 ± 0.9765 mV
in BmK IT2 group (n = 5, p < 0.05), −30.14 ± 1.741 mV
in BmK IT2-mix group (Table 1, n = 5, p > 0.05), and
−25.68 ± 1.813 mV in control group (n = 6), respectively.
The slope factors (Ka) did not present obvious changes in
BmK IT2 (Ka = 4.486 ± 0.3817, n = 5) and BmK IT2-mix
group (Ka = 5.815 ± 0.7268, n = 5), compared with the con-
trol group (Fig. 2b, Table 1, n = 6, p > 0.05).
The voltage-dependent steady-state inactivation of
DRG-type sodium channels was determined by eliciting
400-ms conditioning pulses to voltages between −140
and 0 mV in 10 mV increments followed by a 80 ms
standard test pulse to 0 mV. The currents were also nor-
malized and were calculated as relative conductance.
Data were fit with a Boltzmann function to draw the
conductance-voltage (G-V) curve (Fig. 3a and b). The
half-inactivation voltage (V1/2-i) and the slope factor (Ki)
were calculated (Table 1). No significant difference was
discovered in BmK I (n = 5, p > 0.05), BmK I-mix (n = 5,
p > 0.05) compared to control (Fig. 3a, Table 1, n = 6), as
well as the BmK IT2 (n = 5, p > 0.05), BmK IT2-mix (n = 5,
p > 0.05) compared to control (Fig. 3b, Table 1, n = 6).
Eventually co-applied BmK I and BmK IT2 did not
modulate the steady-state inactivation of ND7-23 cells
currents.
Inhibition of open-state inactivation of DRG-type sodium
channels
In order to confirm the modulative effects of BmK I and
BmK IT2 on open-state inactivation, the inactivation
phase of INa tracings was analyzed by fitting to single ex-
ponential function. The time constants from the peak
value to the persistent current were calculated before and
after applied BmK I and BmK IT2 at 10 mV to 30 mV.
The inactivation of sodium channels in ND7-23 was slo-
wed down in BmK I group, BmK I-mix group and BmK
IT2-mix group (Fig. 1a and b). When the ND7-23 cells
were applied with BmK I, the time constant was signifi-
cantly increased to 6.982 ± 0.5973 ms (n = 10, p < 0.01),
6.881 ± 0.7093 ms (n = 10, p < 0.05) and 7.132 ± 0.6140 ms
(n = 10, p < 0.05) respectively at 10 mV, 20 mV and 30 mV
Fig. 2 Effect of BmK I and BmK IT2 on the voltage dependence of steady-state activation. a The G-V curve of steady-state activation in the
absence (n = 6), presence of 400 nM BmK I (n = 5) and in presence of 400 nM BmK I and 400 BmK IT2 (n = 5). b The G-V curve of steady-state
activation in the absence (n = 6), presence of 400 nM BmK IT2 (n = 5) and in presence of 400 nM BmK I and 400 BmK IT2 (n = 5)
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while it was 4.223 ± 0.4944 ms (n = 10), 4.902 ± 0.6564 ms
(n = 10) and 5.203 ± 0.6961 ms (n = 10) in control (Fig. 4a).
In addition, the open-state inactivation of VGSCs in BmK
I-mix group was still slower than in control group with
the time constant of 6.306 ± 0.3762 ms (n = 6, p < 0.05),
6.371 ± 0.4289 ms (n = 6, p < 0.05) and 6.499 ± 0.4195 ms
(n = 6, p < 0.05) at 10 mV, 20 mV and 30 mV (Fig. 4a).
BmK IT2-mix group was shared an similar property, and
the time constant was 6.710 ± 0.7331 ms (n = 9, p < 0.05),
7.284 ± 0.5559 ms (n = 9, p < 0.05) and 7.320 ± 0.6516 ms
(n = 9, p < 0.05) in BmK IT2-mix group compared to
4.666 ± 0.5358 ms (n = 9), 5.899 ± 0.6654 ms (n = 9) and
5.499 ± 0.6426 ms (n = 9) in control group (Fig. 4b). BmK
IT2 did not prolong the time constant of open-state
inactivation, whose time constant was 4.854 ± 0.7474 ms
(n = 5, p > 0.05), 5.138 ± 0.5182 ms (n = 5, p > 0.05) and
6.479 ± 0.8902 ms (n = 5, p > 0.05) (Fig. 4b).
Discussion
In this study, the positive synergistic effect of BmK I and
BmK IT2 on ND7-23 endogenous VGSCs was identified
by whole cell patch clamp. From our results, we found out
that BmK IT2 enhanced the pharmacological effect of
BmK I by eliciting a higher peak current (Fig. 1c) and
shifting the voltage-dependent activation to more hyper-
polarized potential (Fig. 2a). The steady-state inactivation
of VGSCs was not affected by co-applying BmK I and
BmK IT2 (Fig. 3), which indicated that positive synergistic
effect brought no extra effect on other pharmacological
properties of sodium channels. It has been reported that
the performance of site-3 toxins was enhanced by site-4
toxins in insects based on toxicity assays and binding ex-
periments [15]. Our work provides another evidence of
positive synergistic effect induced by two toxins on mam-
malian VGSCs by studying the modulation of gating prop-
erties, not the toxicity or binding experiments as
previously done [15].
BmK I acts as a receptor site-3 modulator while BmK
IT2 modulates sodium channels by binding to receptor
site 4. It has been reported that the sensitivity of the re-
ceptor site 3 can be enhanced by specific ligands of an-
other receptor site. For instance, brevetoxin (Pbtx-1)
bound to receptor site-5 has positive allosteric modula-
tion on LqhαITa site-3 toxin binding to insect sodium
channels [16, 17]. In this case, we speculated that BmK
IT2 seems to play a similar role as Pbtx-1. BmK IT2,
binding to receptor site 4, may induce a conformational
change on the channels. Moreover, the conformational
change of channels not only modulates gating properties
but also affect the binding of BmK I to receptor site 3.
As was previously reported, receptor site 4 is mainly
assigned to the S3-S4 in domain II, whereas site 3
Table 1 Parameters for voltage dependence of steady-state activation and steady-state inactivation of the DRG-type sodium
channels
Steady-state activation Steady-state inactivation
V1/2-a Ka V1/2-i Ki n
Control −30.0 ± 1.22 6.90 ± 0.54 −71.9 ± 0.90 6.97 ± 0.66 6
BmK I −42.0 ± 1.31* 7.05 ± 0.52 −75.6 ± 1.07 10.25 ± 0.64 5
BmK I-mix −48.6 ± 1.40** 3.29 ± 0.49* −76.8 ± 0.62 9.26 ± 0.33 5
Control −25.7 ± 1.81 4.27 ± 0.59 −69.2 ± 1.12 7.78 ± 0.67 6
BmK IT2 −38.1 ± 0.98* 4.48 ± 0.38 −72.2 ± 0.86 7.91 ± 0.36 5
BmK IT2-mix −30.1 ± 1.74 5.81 ± 0.73 −71.6 ± 1.06 9.84 ± 0.56 5
*p < 0.05, **p < 0.01, significant difference to control (one-way ANOVA, Tukey test)
Fig. 3 Effect of BmK I and BmK IT2 on the voltage dependence of steady-state inactivation. a The G-V curve of the steady-state inactivation in
the absence (n = 6), presence of 400 nM BmK I (n = 5) and in presence of 400 nM BmK I and 400 BmK IT2 (n = 5). b The G-V curve of the steady-
state inactivation in the absence (n = 6), presence of 400 nM BmK IT2 (n = 5) and in presence of 400 nM BmK I and 400 BmK IT2 (n = 5)
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involves S3-S4 in domain IV [18, 19]. The coupling
interaction among voltage sensors of sodium channels
has been reported, the positive synergistic effect of BmK
I and BmK IT2 may be attributed to the allosteric inter-
action between receptor site 3 and site 4 [20–22].
It is worth noting that the peak current of sodium
channels was not significantly enhanced in BmK IT2-
mix group. The conductance-voltage curve in BmK IT2-
mix group shifted less significantly than that in BmK
IT2 group (Fig. 1d, Fig. 2b). The results suggested that
BmK IT2 has two different sites for binding to DRG
neuron-specific sodium channels. One was probably lo-
cated in receptor site 4; the other was possibly located in
receptor site 3. When the channels were treated with
BmK I, BmK IT2 tended to bond to site 4. Moreover,
BmK IT2 could bond to site 3 when the channels were
pretreated with BmK IT2. BmK IT2 might share a simi-
lar binding property as BmK AS [23, 24].
Previous study showed that BmK I, the main lethal
component of BmK venom, may induce various nocicep-
tion behaviors in rats [8]. However, purified BmK I did
not trigger higher pain levels in the same dosage of BmK
venoms, though the pain response was dose-dependent
[6, 8]. Besides, some other components, such as BmK
IT2, performed anti-nociception effect in inflammatory
pain model induced by formalin [10, 11]. Our results ex-
plained the severe pain induced by BmK venom and a
novel perspective of scorpion sting induced pain. The
non-toxic truncated β-toxins (ΔΔBj-xtrIT and ΔΔCss4)
have been confirmed to be capable of modulating the
binding and effects of site-3 scorpion α-toxins LqhαIT
in an allosteric manner [25]. Similarly, both the toxicity
and the content of BmK IT2 are much lower than that
of BmK I. Considering that there are 100 to 300 peptides
found in scorpion venom and most of them only have
low toxicity. Our finding suggested a new functional role
of non-lethal polypeptides in enhancing the effect of
other active neurotoxins (the scorpion venom). This may
be one of the reasons to explain why these non-lethal
components have not disappeared over the course of
animal evolution.
Conclusions
The present results provide evidence that site-4 toxin
(BmK IT2) could enhance the pharmacological effects of
site-3 toxin (BmK I) on mammalian voltage-gated so-
dium channels. Meanwhile, this study declares that the
allosteric interaction among different receptor sites play
an important role in scorpion sting-induced pain.
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